Publications by authors named "Dylan Fingerman"

Claim this Profile
C
Clonal dynamics shaped by diverse drug-tolerant persister states in melanoma resistance.
Haiyin Li, Yeqing Chen, Jessica Kaster, Maggie Dunne, Min Xiao, Dylan Fingerman

bioRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APOBEC3A drives ovarian cancer metastasis by altering epithelial-mesenchymal transition.
Jessica M Devenport, Thi Tran, Brooke R Harris, Dylan Fingerman, Rachel A DeWeerd

JCI Insight· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APOBEC3A drives metastasis of high-grade serous ovarian cancer by altering epithelial-to-mesenchymal transition.
Jessica M Devenport, Thi Tran, Brooke R Harris, Dylan F Fingerman, Rachel A DeWeerd

bioRxiv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SMC5/6 complex prevents genotoxicity upon APOBEC3A-mediated replication stress.
Dylan F Fingerman, David R O'Leary, Ava R Hansen, Thi Tran, Brooke R Harris

EMBO J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SMC5/6 complex prevents genotoxicity upon APOBEC3A-mediated replication stress.
David R O'Leary, Ava R Hansen, Dylan F Fingerman, Thi Tran, Brooke R Harris

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma.
Kasturee Jagirdar, Marie E Portuallo, Meihan Wei, Matthew Wilhide, Jeremy A Bravo Narula, Dylan Fingerman

Oncogene· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells.
Yogesh Goyal, Gianna T Busch, Maalavika Pillai, Jingxin Li, Ryan H Boe, Dylan Fingerman

Nature· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERK Hyperactivation Serves as a Unified Mechanism of Escape in Intrinsic and Acquired CDK4/6 Inhibitor Resistance in Acral Lentiginous Melanoma.
Vito Rebecca, Kasturee Jagirdar, Marie Portuallo, Meihan Wei, Matthew Wilhide, Dylan Fingerman

Res Sq· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting UGCG Overcomes Resistance to Lysosomal Autophagy Inhibition.
Vaibhav Jain, Sandra L Harper, Amanda M Versace, Dylan Fingerman, Gregory Schuyler Brown

Cancer Discov· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas.
Vito W Rebecca, Min Xiao, Andrew Kossenkov, Tetiana Godok, Gregory Schuyler Brown, Dylan Fingerman

bioRxiv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MFF Regulation of Mitochondrial Cell Death Is a Therapeutic Target in Cancer.
Jae Ho Seo, Young Chan Chae, Andrew V Kossenkov, Yu Geon Lee, Hsin-Yao Tang, Dylan Fingerman

Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model.
Lorenz Loyola, Vasudevan Achuthan, Kathryn Gilroy, Gillian Borland, Anna Kilbey, Dylan Fingerman

PLoS Pathog· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis